← Back to BRTX

BioRestorative Therapies, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSMar 2026Filed 14/05/2026Sep 2025Filed 12/11/2025Jun 2025Filed 12/11/2025Mar 2025Filed 14/05/2026Sep 2024Filed 12/11/2025Jun 2024Filed 12/11/2025Mar 2024Filed 12/11/2025Sep 2023Filed 12/11/2024
$0$0$0.3$0$0.2$0.1$0$0
−$2.2−$3−$2.7−$5.3−$1.1−$4−$2.2$4.8
−$0.12−$0.33−$0.30−$0.64−$0.13−$0.50−$0.33$0.39
189.18.78.48.18.16.712

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.